Metraipolis › archive › dc_5216379ff660

RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery System — Europe PMC PMID:41718318

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41718318
DOI
10.3390/mps9010016
License (as archived)
solo-consultazione
Archived
2026-11-06T15:09:43.737Z
SHA-256 of the archived text
b2fd00bdcc9541c3d299a450299aba71fa7a394d6e66b831e3f50a9ceaf742c9
Stable URL of this page
https://metraipolis.com/documento/dc_5216379ff660

How to cite

RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery System — Europe PMC PMID:41718318 — Europe PMC (en), https://europepmc.org/article/MED/41718318 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5216379ff660 (Metraipolis archive dc_5216379ff660, sha256 b2fd00bdcc9541c3d299a450299aba71fa7a394d6e66b831e3f50a9ceaf742c9)
BibTeX
@misc{dc5216379ff660,
  title = {RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery System — Europe PMC PMID:41718318},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41718318},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5216379ff660; sha256 b2fd00bdcc9541c3d299a450299aba71fa7a394d6e66b831e3f50a9ceaf742c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41718318. Agents can read the archived copy with the MCP tool read_document.